Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Cavalry who wrote (1634)	7/21/1998 1:21:00 PM
From: Jeffrey S. Mitchell	Read Replies (2) \| Respond to of 4028

Cav, did you know that gene transfer therapy has been around since 1968? It's hardly new. Finding the right vector, the one that will transfer the necessary DNA into the cell without destroying the cell or infecting the patient, is like looking for the holy grail. It's not a search for gold, it's a step by step painstaking laboratory process that leaves behind it stacks of published material in medical journals. Where is the documentation? Heck, we don't even know if we're talking mmlv, adeno, aav, etc. I don't doubt CYGS has a vector. However, I do doubt a company with a PO Box for an office has one of any value. No, the value is in pretending they have one of value with no published research to prove or disprove otherwise. - Jeff